Your browser doesn't support javascript.
loading
Recipient risk factors for acute cellular rejection after orthotopic liver transplant - a single-center, retrospective study.
Choi, David; Liu, Mengyuan; Guttikonda, Dharani; Galen, Kelly; Guzman, Grace; Jeon, Hoonbae; Aloman, Costica.
Afiliação
  • Choi D; Division of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
  • Liu M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
  • Guttikonda D; Division of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
  • Galen K; Division of Digestive Diseases and Nutrition, Section of Hepatology, Rush University, Chicago, IL, USA.
  • Guzman G; Division of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, IL, USA.
  • Jeon H; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
  • Aloman C; Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Transpl Int ; 33(12): 1779-1787, 2020 12.
Article em En | MEDLINE | ID: mdl-32990344
ABSTRACT
The use of model for end-stage liver disease (MELD) score for liver allocation has resulted in transplanting sicker patients. As such, it is unclear whether the risk factors and severity of acute cellular rejection (ACR) have changed. To identify ACR characteristics where average MELD score at transplant is higher than previously published studies. This is a single-center, retrospective study designed to assess risk factors associated with ACR after adult orthotopic liver transplant (OLT) using a steroid sparing regimen. This study included 174 OLT patients transplanted from 2008 to 2013 at a single tertiary care center. Recipient demographics, preoperative clinical, and laboratory data were recorded for each transplant. Univariate and multivariate regression analyses were performed to identify variables that are significant predictors for ACR. The median MELD at transplantation was 29.5. The average time from transplant to ACR diagnosis was 283.9 days and a majority of ACR episodes were mild to moderate. Serum creatinine, primary sclerosing cholangitis etiology, and tacrolimus use were significant predictors for ACR (P < 0.05). This study confirmed a change in timing and severity of ACR in the MELD era. Recipient characteristics may affect the risk for developing ACR and should be considered when managing immunosuppression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article